Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 250-254
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.250
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.250
Table 1 Serum ALT, AST, NO2-/NO3- and hepatic NOS activity (-x±s)
Group | n | ALT | AST | NO2-/NO3- | NOS |
(nkat/L) | (nkat/L) | (μmol/L) | (KU/g) | ||
Control | 10 | 35.8 ± 7.9 | 64.5 ± 20.8 | 21.8 ± 13.7 | 0.65 ± 0.08 |
Ovx | 10 | 31.6 ± 6.5 | 66.4 ± 18.3 | 19.3 ± 11.2 | 0.54 ± 0.33 |
Ovx+E | 9 | 38.5 ± 11.2 | 68.4 ± 21.2 | 84.8 ± 24.9ac | 2.57 ± 1.06ac |
CCl4 | 9 | 540 ± 252a | 631 ± 268a | 55.3 ± 23.1a | 1.65 ± 0.46a |
CCl4+Ovx | 10 | 658 ± 220a | 697 ± 240a | 53.7 ± 17.1a | 1.73 ± 0.71a |
CCl4+E | 8 | 314 ± 163c | 302 ± 153c | 87.5 ± 23.6c | 2.68 ± 1.17c |
CCl4+Ovx+E | 9 | 311 ± 146c | 321 ± 121c | 93.3 ± 24.2c | 2.49 ± 1.20c |
- Citation: Xu JW, Gong J, Chang XM, Luo JY, Dong L, Jia A, Xu GP. Effects of estradiol on liver estrogen receptor-α and its mRNA expression in hepatic fibrosis in rats. World J Gastroenterol 2004; 10(2): 250-254
- URL: https://www.wjgnet.com/1007-9327/full/v10/i2/250.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i2.250